Last reviewed · How we verify

NCT04003194

Pinto Beans and Glycemic Control in Adults With Type 2 Diabetes

Completed NA Last updated 1 July 2019
What this trial tests

NA trial testing Pinto Beans in Type 2 Diabetes in 13 participants. Completed in 31 December 2010.

Timeline
1 March 2009
Primary endpoint
31 December 2010
31 December 2010

Quick facts

Lead sponsorUniversity of Colorado, Colorado Springs
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment13
Start date1 March 2009
Primary completion31 December 2010
Estimated completion31 December 2010

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Colorado Springs

Who can join

Adults 20 to 75, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines the impact of daily consumption of ½ c pinto beans, compared to a control (½ c green beans), on fasting glucose, postprandial glucose and HbA1c concentrations in adults with type 2 diabetes mellitus (T2DM).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

Other University of Colorado, Colorado Springs trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04003194.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing